Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2012 2
2013 2
2014 3
2015 1
2017 6
2018 4
2019 6
2020 10
2021 7
2022 5
2023 4
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
BTS Clinical Statement on pulmonary sarcoidosis.
Thillai M, Atkins CP, Crawshaw A, Hart SP, Ho LP, Kouranos V, Patterson K, Screaton NJ, Whight J, Wells AU. Thillai M, et al. Thorax. 2021 Jan;76(1):4-20. doi: 10.1136/thoraxjnl-2019-214348. Epub 2020 Dec 2. Thorax. 2021. PMID: 33268456 Review. No abstract available.
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study.
Desai SR, Sivarasan N, Johannson KA, George PM, Culver DA, Devaraj A, Lynch DA, Milne D, Renzoni E, Nunes H, Sverzellati N, Spagnolo P, Baughman RP, Yadav R, Piciucchi S, Walsh SLF, Kouranos V, Wells AU; Sarcoid Delphi Group. Desai SR, et al. Lancet Respir Med. 2024 May;12(5):409-418. doi: 10.1016/S2213-2600(23)00267-9. Epub 2023 Dec 14. Lancet Respir Med. 2024. PMID: 38104579 Review.
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.
Wu Z, Spencer LG, Banya W, Westoby J, Tudor VA, Rivera-Ortega P, Chaudhuri N, Jakupovic I, Patel B, Thillai M, West A, Wijsenbeek M, Maher TM, Smith JA, Molyneaux PL. Wu Z, et al. Among authors: thillai m. Lancet Respir Med. 2024 Apr;12(4):273-280. doi: 10.1016/S2213-2600(23)00432-0. Epub 2024 Jan 15. Lancet Respir Med. 2024. PMID: 38237620 Free article. Clinical Trial.
Update on sarcoidosis guidelines.
Millward K, Fiddler CA, Thillai M. Millward K, et al. Among authors: thillai m. Curr Opin Pulm Med. 2021 Sep 1;27(5):484-489. doi: 10.1097/MCP.0000000000000807. Curr Opin Pulm Med. 2021. PMID: 34261085 Review.
Lung transplantation for idiopathic pulmonary fibrosis.
George PM, Patterson CM, Reed AK, Thillai M. George PM, et al. Among authors: thillai m. Lancet Respir Med. 2019 Mar;7(3):271-282. doi: 10.1016/S2213-2600(18)30502-2. Epub 2019 Feb 6. Lancet Respir Med. 2019. PMID: 30738856 Review.
Asthma, ECMO and eosinophils.
McLellan T, Patvardhan C, Rassl D, Jenkins HS, Knolle M, Thillai M. McLellan T, et al. Among authors: thillai m. Thorax. 2021 Jul;76(7):737-739. doi: 10.1136/thoraxjnl-2020-216052. Epub 2021 Jan 25. Thorax. 2021. PMID: 33495316 No abstract available.
52 results